Kiora Pharmaceuticals Inc
KPRX· Nasdaq
Released Mar 25, 2026, before the open
10-K filed Mar 25, 2026, 84 days after period end · 0001372514-26-000024
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$6.52M |
Kiora Pharmaceuticals Inc · CIK 1372514 · Engraved from SEC EDGAR
| -$4.22M |
| -$2.27M |
| -$2.50M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.